Valuation: Stem Cells Spin S.A.

Market Cap	21.08M 5.58M 4.84M 4.57M 4.15M 7.78M 535M 7.82M 54.56M 271M 20.96M 20.49M 865M	P/E 2024	-15.6x	P/E 2025	-31.9x
Enterprise Value	21.17M 5.6M 4.85M 4.59M 4.17M 7.81M 537M 7.85M 54.78M 273M 21.04M 20.58M 869M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	19.04%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news: Stem Cells Spin S.A.

08-14	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-16	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-14	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
15/08/24	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
14/11/23	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

More news

Managers and Directors: Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	01/01/2017

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	28/06/2022
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	15/03/2022

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	0.00%	+4.08%	+15.91%	+24.39%	5.58M
LONZA GROUP AG	+0.19%	+1.16%	-0.84%	+27.55%	45.91B
IQVIA HOLDINGS INC.	-0.32%	+4.61%	+43.90%	+26.98%	44.25B
REVOLUTION MEDICINES, INC.	-4.36%	-5.66%	+338.30%	+516.88%	41.99B
BEONE MEDICINES AG	+0.46%	-0.83%	+6.38%	+73.76%	39.58B
CELLTRION, INC.	-0.17%	-3.22%	+10.29%	+38.69%	31.08B
MEDPACE HOLDINGS, INC.	-0.65%	+5.14%	+25.61%	+120.17%	17.21B
ASCENDIS PHARMA A/S	+3.30%	-5.03%	-	-	16.27B
EUROFINS SCIENTIFIC SE	+2.06%	+7.45%	+21.38%	+38.50%	14.96B
ICON PUBLIC LIMITED COMPANY	+0.86%	+9.05%	+0.47%	-33.54%	13.42B
Average	+0.13%	+1.27%	+51.27%	+92.60%	26.47B
Weighted average by Cap.	-0.35%	+0.31%	+70.24%	+122.70%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

11-16 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
16/09/26	PLN 0.5100	0.00%	159
15/09/26	PLN 0.5100	+6.25%	13
14/09/26	PLN 0.4800	-2.04%	350
11/09/26	PLN 0.4900	-2.00%	1,470
10/09/26	PLN 0.5000	+2.04%	180

End-of-day quote Warsaw S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. 16/09/2026			5-day change	1st Jan Change
0.5100 ^PLN	0.00%		+4.08%	+25.62%

1 week	+4.08%
Current month	+8.05%
1 month	+6.69%
3 months	+22.60%
6 months	+34.21%
Current year	+25.62%

1 week	0.48	0.52
1 month	0.45	0.53
Current year	0.33	0.54
1 year	0.28	0.54
3 years	0.14	0.82
5 years	0.14	1.12
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 14.37K 12.45K 11.77K 10.68K 20.02K 1.38M 20.14K 140K 699K 53.97K 52.77K 2.23M	65.74K 17.4K 15.08K 14.25K 12.94K 24.25K 1.67M 24.39K 170K 847K 65.35K 63.9K 2.7M
Net income	-520K -138K -119K -113K -102K -192K -13.21M -193K -1.35M -6.7M -517K -506K -21.36M	-526K -139K -121K -114K -103K -194K -13.35M -195K -1.36M -6.77M -523K -511K -21.58M
Net Debt	69.28K 18.34K 15.89K 15.02K 13.64K 25.56K 1.76M 25.71K 179K 892K 68.88K 67.35K 2.84M	84.58K 22.39K 19.4K 18.34K 16.65K 31.2K 2.15M 31.39K 219K 1.09M 84.09K 82.23K 3.47M

Stem Cells Spin S.A. Stock

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation: Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news: Stem Cells Spin S.A.

Quotes and Performance

Price Extremes

Managers and Directors: Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes